| Literature DB >> 22146722 |
Sachiko Shiba1, Nobuyo Tsunoda, Masaki Wakutsu, Etsuko Muraki, Mariko Sonoda, Phyllis S Y Tam, Yoko Fujiwara, Shinji Ikemoto, Keizo Kasono.
Abstract
We investigated whether oral administration of palmitoleate ameliorates disorders of lipid metabolism to clarify the effects of one of the components of fish oil. Lipid levels in the liver and plasma were significantly decreased by palmitoleate and by EPA administration. These results suggest that palmitoleate, in addition to EPA, plays a role in the regulation of lipid metabolism by fish oil.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22146722 DOI: 10.1271/bbb.110509
Source DB: PubMed Journal: Biosci Biotechnol Biochem ISSN: 0916-8451 Impact factor: 2.043